Logo image of MDV

MODIV INDUSTRIAL INC (MDV) Stock Fundamental Analysis

NYSE:MDV - New York Stock Exchange, Inc. - US60784B1017 - REIT - Currency: USD

14.35  0 (0%)

After market: 14.35 0 (0%)

Fundamental Rating

4

Taking everything into account, MDV scores 4 out of 10 in our fundamental rating. MDV was compared to 130 industry peers in the Diversified REITs industry. MDV has an average financial health and profitability rating. MDV does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

5

1. Profitability

1.1 Basic Checks

In the past year MDV has reported negative net income.
MDV had a positive operating cash flow in the past year.
MDV had negative earnings in 4 of the past 5 years.
In the past 5 years MDV always reported a positive cash flow from operatings.
MDV Yearly Net Income VS EBIT VS OCF VS FCFMDV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 -20M -40M -60M -80M -100M

1.2 Ratios

MDV's Return On Assets of -0.12% is on the low side compared to the rest of the industry. MDV is outperformed by 60.00% of its industry peers.
Looking at the Return On Equity, with a value of -0.35%, MDV is doing worse than 60.00% of the companies in the same industry.
MDV's Return On Invested Capital of 3.12% is fine compared to the rest of the industry. MDV outperforms 60.77% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for MDV is in line with the industry average of 3.16%.
The last Return On Invested Capital (3.12%) for MDV is above the 3 year average (2.12%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -0.12%
ROE -0.35%
ROIC 3.12%
ROA(3y)-1.01%
ROA(5y)-3.09%
ROE(3y)-3.42%
ROE(5y)-9.27%
ROIC(3y)2.12%
ROIC(5y)1.53%
MDV Yearly ROA, ROE, ROICMDV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 0 -10 -20 -30

1.3 Margins

Looking at the Operating Margin, with a value of 42.50%, MDV belongs to the top of the industry, outperforming 87.69% of the companies in the same industry.
In the last couple of years the Operating Margin of MDV has grown nicely.
Looking at the Gross Margin, with a value of 92.54%, MDV belongs to the top of the industry, outperforming 94.62% of the companies in the same industry.
MDV's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 42.5%
PM (TTM) N/A
GM 92.54%
OM growth 3Y67.86%
OM growth 5Y18.86%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.08%
GM growth 5Y2.86%
MDV Yearly Profit, Operating, Gross MarginsMDV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

More info and screens

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), MDV is destroying value.
The number of shares outstanding for MDV has been increased compared to 1 year ago.
Compared to 5 years ago, MDV has more shares outstanding
Compared to 1 year ago, MDV has a worse debt to assets ratio.
MDV Yearly Shares OutstandingMDV Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
MDV Yearly Total Debt VS Total AssetsMDV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

2.2 Solvency

MDV has an Altman-Z score of 0.10. This is a bad value and indicates that MDV is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.10, MDV is doing worse than 72.31% of the companies in the same industry.
The Debt to FCF ratio of MDV is 25.54, which is on the high side as it means it would take MDV, 25.54 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of MDV (25.54) is better than 73.85% of its industry peers.
MDV has a Debt/Equity ratio of 1.63. This is a high value indicating a heavy dependency on external financing.
MDV has a Debt to Equity ratio of 1.63. This is in the lower half of the industry: MDV underperforms 65.38% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.63
Debt/FCF 25.54
Altman-Z 0.1
ROIC/WACC0.55
WACC5.71%
MDV Yearly LT Debt VS Equity VS FCFMDV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

2.3 Liquidity

A Current Ratio of 4.88 indicates that MDV has no problem at all paying its short term obligations.
MDV has a Current ratio of 4.88. This is amongst the best in the industry. MDV outperforms 94.62% of its industry peers.
A Quick Ratio of 4.88 indicates that MDV has no problem at all paying its short term obligations.
MDV has a better Quick ratio (4.88) than 94.62% of its industry peers.
Industry RankSector Rank
Current Ratio 4.88
Quick Ratio 4.88
MDV Yearly Current Assets VS Current LiabilitesMDV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 87.50% over the past year.
MDV shows a decrease in Revenue. In the last year, the revenue decreased by -4.13%.
MDV shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 13.76% yearly.
EPS 1Y (TTM)87.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-103.03%
Revenue 1Y (TTM)-4.13%
Revenue growth 3Y7.26%
Revenue growth 5Y13.76%
Sales Q2Q%-1.45%

3.2 Future

Based on estimates for the next years, MDV will show a small growth in Earnings Per Share. The EPS will grow by 2.94% on average per year.
Based on estimates for the next years, MDV will show a small growth in Revenue. The Revenue will grow by 2.34% on average per year.
EPS Next Y-69.03%
EPS Next 2Y-23.9%
EPS Next 3Y2.94%
EPS Next 5YN/A
Revenue Next Year2.68%
Revenue Next 2Y3.56%
Revenue Next 3Y2.24%
Revenue Next 5Y2.34%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
MDV Yearly Revenue VS EstimatesMDV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 10M 20M 30M 40M 50M
MDV Yearly EPS VS EstimatesMDV Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 0 -0.5 -1 -1.5

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

MDV reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Based on the Price/Forward Earnings ratio of 99.13, the valuation of MDV can be described as expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of MDV is on the same level as its industry peers.
Compared to an average S&P500 Price/Forward Earnings ratio of 36.21, MDV is valued quite expensively.
Industry RankSector Rank
PE N/A
Fwd PE 99.13
MDV Price Earnings VS Forward Price EarningsMDV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 -50 -100 -150

4.2 Price Multiples

70.77% of the companies in the same industry are more expensive than MDV, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of MDV indicates a rather cheap valuation: MDV is cheaper than 86.92% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 13.26
EV/EBITDA 11.61
MDV Per share dataMDV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-23.9%
EPS Next 3Y2.94%

More info and screens

4

5. Dividend

5.1 Amount

MDV has a Yearly Dividend Yield of 8.01%, which is a nice return.
MDV's Dividend Yield is a higher than the industry average which is at 6.45.
Compared to an average S&P500 Dividend Yield of 2.39, MDV pays a better dividend.
Industry RankSector Rank
Dividend Yield 8.01%

5.2 History

MDV has paid a dividend for less than 5 years, so there is no long track record yet.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years2
MDV Yearly Dividends per shareMDV Yearly Dividends per shareYearly Dividends per share 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

MDV has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-2417.04%
EPS Next 2Y-23.9%
EPS Next 3Y2.94%
MDV Yearly Income VS Free CF VS DividendMDV Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2017 2018 2019 2020 2021 2022 2023 2024 0 -20M -40M -60M -80M -100M

More info and screens

MODIV INDUSTRIAL INC

NYSE:MDV (8/1/2025, 8:04:01 PM)

After market: 14.35 0 (0%)

14.35

0 (0%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)05-07 2025-05-07/bmo
Earnings (Next)08-07 2025-08-07/bmo
Inst Owners17.04%
Inst Owner Change0.37%
Ins Owners2.92%
Ins Owner Change1.75%
Market Cap145.22M
Analysts84.44
Price Target18.05 (25.78%)
Short Float %3.16%
Short Ratio4.15
Dividend
Industry RankSector Rank
Dividend Yield 8.01%
Yearly Dividend1.6
Dividend Growth(5Y)N/A
DP-2417.04%
Div Incr Years0
Div Non Decr Years2
Ex-Date09-30 2025-09-30 (0.0975)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)143.79%
Min EPS beat(2)88.58%
Max EPS beat(2)199.01%
EPS beat(4)3
Avg EPS beat(4)-61.77%
Min EPS beat(4)-694.06%
Max EPS beat(4)199.01%
EPS beat(8)5
Avg EPS beat(8)48.97%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.66%
Min Revenue beat(2)-0.61%
Max Revenue beat(2)1.93%
Revenue beat(4)2
Avg Revenue beat(4)-0.43%
Min Revenue beat(4)-4.05%
Max Revenue beat(4)1.93%
Revenue beat(8)4
Avg Revenue beat(8)0.05%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-1.67%
EPS NQ rev (1m)0%
EPS NQ rev (3m)200%
EPS NY rev (1m)0%
EPS NY rev (3m)169.7%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.46%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.26%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 99.13
P/S 3.12
P/FCF 13.26
P/OCF 7.93
P/B 0.85
P/tB 0.85
EV/EBITDA 11.61
EPS(TTM)-0.09
EYN/A
EPS(NY)0.14
Fwd EY1.01%
FCF(TTM)1.08
FCFY7.54%
OCF(TTM)1.81
OCFY12.6%
SpS4.6
BVpS16.91
TBVpS16.79
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.12%
ROE -0.35%
ROCE 3.95%
ROIC 3.12%
ROICexc 3.16%
ROICexgc 3.19%
OM 42.5%
PM (TTM) N/A
GM 92.54%
FCFM 23.51%
ROA(3y)-1.01%
ROA(5y)-3.09%
ROE(3y)-3.42%
ROE(5y)-9.27%
ROIC(3y)2.12%
ROIC(5y)1.53%
ROICexc(3y)2.16%
ROICexc(5y)1.58%
ROICexgc(3y)2.18%
ROICexgc(5y)1.6%
ROCE(3y)2.69%
ROCE(5y)1.95%
ROICexcg growth 3Y59.93%
ROICexcg growth 5Y30.52%
ROICexc growth 3Y62.55%
ROICexc growth 5Y34.05%
OM growth 3Y67.86%
OM growth 5Y18.86%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.08%
GM growth 5Y2.86%
F-Score5
Asset Turnover0.09
Health
Industry RankSector Rank
Debt/Equity 1.63
Debt/FCF 25.54
Debt/EBITDA 7.75
Cap/Depr 45.14%
Cap/Sales 15.78%
Interest Coverage 1.5
Cash Conversion 50.72%
Profit Quality N/A
Current Ratio 4.88
Quick Ratio 4.88
Altman-Z 0.1
F-Score5
WACC5.71%
ROIC/WACC0.55
Cap/Depr(3y)581.06%
Cap/Depr(5y)371.93%
Cap/Sales(3y)189.95%
Cap/Sales(5y)123.43%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)87.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-103.03%
EPS Next Y-69.03%
EPS Next 2Y-23.9%
EPS Next 3Y2.94%
EPS Next 5YN/A
Revenue 1Y (TTM)-4.13%
Revenue growth 3Y7.26%
Revenue growth 5Y13.76%
Sales Q2Q%-1.45%
Revenue Next Year2.68%
Revenue Next 2Y3.56%
Revenue Next 3Y2.24%
Revenue Next 5Y2.34%
EBIT growth 1Y117.17%
EBIT growth 3Y80.05%
EBIT growth 5Y35.21%
EBIT Next Year80.32%
EBIT Next 3Y29.12%
EBIT Next 5YN/A
FCF growth 1Y114.09%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-10.76%
OCF growth 3Y23.3%
OCF growth 5Y30.88%